Spectral Diagnostics (OTCMKTS:EDTXF) Shares Down 0.7% - Here's Why

Key Points

• Shares of Spectral Diagnostics Inc. (OTCMKTS:EDTXF) experienced a decline of 0.7%, trading at $1.06 with an 80% decrease in volume compared to the average session.
• The company has a market capitalization of $305.23 million and a negative PE ratio of -15.14, indicating financial struggles.
• Spectral Medical focuses on developing products for treating septic shock and markets diagnostic and therapeutic devices, including the Endotoxin Activity Assay.

Shares of Spectral Diagnostics Inc. (OTCMKTS:EDTXF - ) fell 0.7% during mid-day trading on Monday . The stock traded as low as $1.06 and last traded at $1.06. 3,338 shares traded hands during trading, a decline of 80% from the average session volume of 16,950 shares. The stock had previously closed at $1.07.

Spectral Diagnostics Price Performance

The company has a market capitalization of $305.23 million, a PE ratio of -15.14 and a beta of 0.26. The company's fifty day moving average is $0.91 and its 200-day moving average is $0.69.

Spectral Diagnostics Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.